publication venue for
- Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica.. 50:255-267. 2024
- The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis: A Scoping Review.. 50:325-335. 2024
- Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management.. 50:269-279. 2024
- Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019.. 49:695-711. 2023
- Taxonomy of Quality of Care Indicators: Tracing the Path from Clinical Practice Guidelines to Quality Measurement and Beyond.. 48:601-615. 2022
- Rheumatic Complications of Immune Checkpoint Inhibitors.. 48:411-428. 2022
- Racial/Ethnic, Socioeconomic, and Geographic Disparities in the Epidemiology of Knee and Hip Osteoarthritis.. 47:1-20. 2020
- Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Is There Still a Role for Cyclophosphamide?. 45:379-398. 2019
- Comorbidities in patients with crystal diseases and hyperuricemia.. 40:251-78. 2014
- Aging or osteoarthritis: which is the problem?. 29:653-73. 2003
- Aging and the etiopathogenesis and treatment of osteoarthritis.. 26:547-67. 2000